• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Soluplus对微粒和无定形固体分散体中厄洛替尼亚稳晶型的稳定作用。

Stabilizing Effect of Soluplus on Erlotinib Metastable Crystal Form in Microparticles and Amorphous Solid Dispersions.

作者信息

Jia Shuyu, Ning Shangqi, Leng Yuting, Jing Qiufang, Xu Zhongyu, Ren Fuzheng

机构信息

Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Engineering Research Center of Pharmaceutical Process Chemistry, Ministry of Education, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.

出版信息

Polymers (Basel). 2022 Mar 19;14(6):1241. doi: 10.3390/polym14061241.

DOI:10.3390/polym14061241
PMID:35335571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8949943/
Abstract

Microparticles (MPs) and amorphous solid dispersions (SDs) are effective methods to improve the dissolution of insoluble drugs. However, stability is a concern for these two high-energy systems, resulting from high surface area and amorphous polymorph, respectively. As an amphiphilic polymer, Soluplus (SOL) is usually used as a carrier in SDs. In this study, erlotinib microparticles (ERL MPs) and erlotinib solid dispersions (ERL SDs) were prepared with SOL by bottom-up technology and solvent evaporation. The solid-state properties of ERL MPs and ERL SDs were characterized by Differential Scanning Calorimetry (DSC), Powder X-Ray Diffraction (PXRD) and Scanning Electron Microscopy (SEM). The ERL MPs existed in a metastable crystal form A while the ERL SDs existed in an amorphous state. Fourier transform infrared spectroscopy (FT-IR) showed that there was a hydrogen bond interaction between the N-H group of ERL and the carbonyl group of SOL in ERL MPs and SDs. The dissolution profiles of ERL SDs and ERL MPs were improved significantly. ERL MPs showed better stability than ERL SDs in accelerated stability test. The discrepant stabilizing effects of polymer SOL in two systems may provide effective ideas for solubilization of insoluble drugs and the stability of drugs after recrystallization.

摘要

微粒(MPs)和无定形固体分散体(SDs)是提高难溶性药物溶出度的有效方法。然而,由于这两种体系分别具有高比表面积和无定形多晶型,稳定性是它们需要关注的问题。作为一种两亲性聚合物,聚乙烯己内酰胺(SOL)通常用作固体分散体的载体。在本研究中,采用自下而上技术和溶剂蒸发法,以SOL制备了厄洛替尼微粒(ERL MPs)和厄洛替尼固体分散体(ERL SDs)。通过差示扫描量热法(DSC)、粉末X射线衍射(PXRD)和扫描电子显微镜(SEM)对ERL MPs和ERL SDs的固态性质进行了表征。ERL MPs以亚稳晶型A存在,而ERL SDs以无定形状态存在。傅里叶变换红外光谱(FT-IR)表明,在ERL MPs和SDs中,ERL的N-H基团与SOL的羰基之间存在氢键相互作用。ERL SDs和ERL MPs的溶出曲线均有显著改善。在加速稳定性试验中,ERL MPs表现出比ERL SDs更好的稳定性。聚合物SOL在两种体系中不同的稳定作用可能为难溶性药物的增溶和药物重结晶后的稳定性提供有效的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/07831d65b156/polymers-14-01241-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/8f6edeee1118/polymers-14-01241-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/186faa54b47a/polymers-14-01241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/0bf899e6230e/polymers-14-01241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/7ae8c1afbc1c/polymers-14-01241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/bffe1c951977/polymers-14-01241-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/484cd4b18054/polymers-14-01241-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/26ca6d152f1d/polymers-14-01241-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/db654a1c64ae/polymers-14-01241-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/60f2f6f0c924/polymers-14-01241-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/07831d65b156/polymers-14-01241-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/8f6edeee1118/polymers-14-01241-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/186faa54b47a/polymers-14-01241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/0bf899e6230e/polymers-14-01241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/7ae8c1afbc1c/polymers-14-01241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/bffe1c951977/polymers-14-01241-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/484cd4b18054/polymers-14-01241-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/26ca6d152f1d/polymers-14-01241-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/db654a1c64ae/polymers-14-01241-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/60f2f6f0c924/polymers-14-01241-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969e/8949943/07831d65b156/polymers-14-01241-g009.jpg

相似文献

1
Stabilizing Effect of Soluplus on Erlotinib Metastable Crystal Form in Microparticles and Amorphous Solid Dispersions.Soluplus对微粒和无定形固体分散体中厄洛替尼亚稳晶型的稳定作用。
Polymers (Basel). 2022 Mar 19;14(6):1241. doi: 10.3390/polym14061241.
2
Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.热分析和傅里叶变换红外光谱曲线拟合技术用于研究非晶态吲哚美辛的形成及其在吲哚美辛-Soluplus®固体分散体中的物理稳定性。
Int J Pharm. 2015 Dec 30;496(2):457-65. doi: 10.1016/j.ijpharm.2015.10.042. Epub 2015 Oct 22.
3
Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement.采用一步法无有机溶剂超临界流体工艺制备辛伐他汀与 Soluplus 的固体分散体以提高药物溶解度和溶出速率
Pharmaceuticals (Basel). 2021 Aug 25;14(9):846. doi: 10.3390/ph14090846.
4
On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.关于 Soluplus 固有性质及其在微波淬火冷却技术制备布洛芬固体分散体中的应用。
Pharm Dev Technol. 2018 Jul;23(6):573-586. doi: 10.1080/10837450.2016.1256409. Epub 2016 Nov 16.
5
Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.制备工艺和老化对NF/Soluplus/聚乙烯吡咯烷酮共聚物固体分散体溶出行为的影响:通过傅里叶变换红外光谱和计算方法的联合分析进行鉴定和分类
Drug Dev Ind Pharm. 2015 Jan;41(1):2-14. doi: 10.3109/03639045.2014.938080. Epub 2014 Jul 15.
6
Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.替米沙坦三元固体分散体的稳定性和生物利用度增强:聚合物和药物-聚合物相互作用的协同效应。
AAPS PharmSciTech. 2019 Mar 18;20(4):143. doi: 10.1208/s12249-019-1358-3.
7
Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.基于 Soluplus®-PEG4000 杂化的格列美脲分子相互作用:特性与抗糖尿病研究。
Int J Pharm. 2015 Dec 30;496(2):741-50. doi: 10.1016/j.ijpharm.2015.11.007. Epub 2015 Nov 12.
8
Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.用于鉴定合适聚合物以抑制拉西地平无定形固体分散体湿度诱导的固态结晶的溶剂转移策略。
Int J Pharm. 2016 Apr 30;503(1-2):238-46. doi: 10.1016/j.ijpharm.2016.01.062. Epub 2016 Feb 8.
9
Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.通过与磷脂的分子复合提高厄洛替尼的口服生物利用度和治疗效果。
Int J Pharm. 2017 Dec 20;534(1-2):1-13. doi: 10.1016/j.ijpharm.2017.09.071. Epub 2017 Sep 29.
10
Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.上下求索:十二烷基硫酸钠和共聚维酮对非洛地平挤出物结晶抑制和溶出的影响
J Pharm Sci. 2018 Sep;107(9):2366-2376. doi: 10.1016/j.xphs.2018.04.025. Epub 2018 May 5.

引用本文的文献

1
Effective and Stable Senomorphic Apigenin Delivery System Obtained by Supercritical Carbon Dioxide Processing.通过超临界二氧化碳处理获得的有效且稳定的类衰老芹菜素递送系统。
Int J Mol Sci. 2025 Aug 22;26(17):8126. doi: 10.3390/ijms26178126.
2
Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies.通过在生物相关介质中进行创新溶出度测试并结合药代动力学研究,开发并表征一种新型口服抗利什曼原虫双(吡啶-2-甲脒)药物。
Pharmaceutics. 2025 Jun 26;17(7):838. doi: 10.3390/pharmaceutics17070838.
3

本文引用的文献

1
Enhancing Biopharmaceutical Attributes of Khellin by Amorphous Binary Solid Dispersions.通过无定形二元固体分散体增强荆芥宁的生物制药属性。
AAPS PharmSciTech. 2021 Oct 27;22(8):260. doi: 10.1208/s12249-021-02126-3.
2
Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement.采用一步法无有机溶剂超临界流体工艺制备辛伐他汀与 Soluplus 的固体分散体以提高药物溶解度和溶出速率
Pharmaceuticals (Basel). 2021 Aug 25;14(9):846. doi: 10.3390/ph14090846.
3
Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization.
A Novel Solid Form of Erlotinib: Synthesis by Heterogeneous Complexation and Characterization by NMR Crystallography.
厄洛替尼的一种新型固体形式:通过非均相络合合成及核磁共振晶体学表征
Cryst Growth Des. 2025 Apr 29;25(9):3219-3228. doi: 10.1021/acs.cgd.5c00268. eCollection 2025 May 7.
4
Self-assembled latanoprost loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma.自组装拉坦前列素载 Soluplus 纳米胶束作为治疗青光眼的眼用药物传递系统。
Sci Rep. 2024 Nov 7;14(1):27051. doi: 10.1038/s41598-024-78244-2.
5
Enhanced Antioxidant and Neuroprotective Properties of Pterostilbene (Resveratrol Derivative) in Amorphous Solid Dispersions.紫檀芪(白藜芦醇衍生物)在无定形固体分散体中的增强抗氧化和神经保护特性
Int J Mol Sci. 2024 Feb 28;25(5):2774. doi: 10.3390/ijms25052774.
6
The Study of Amorphous Kaempferol Dispersions Involving FT-IR Spectroscopy.无定形山柰酚分散体的研究涉及傅里叶变换红外光谱法。
Int J Mol Sci. 2023 Dec 5;24(24):17155. doi: 10.3390/ijms242417155.
7
Amorphous Pterostilbene Delivery Systems Preparation-Innovative Approach to Preparation Optimization.无定形紫檀芪递送系统的制备——制备优化的创新方法
Pharmaceutics. 2023 Apr 13;15(4):1231. doi: 10.3390/pharmaceutics15041231.
含有残余结晶度的无定形固体分散体:溶解和基质结晶之间的竞争。
AAPS J. 2021 May 17;23(4):69. doi: 10.1208/s12248-021-00598-6.
4
Modeling and Simulation of Process Technology for Nanoparticulate Drug Formulations-A Particle Technology Perspective.纳米颗粒药物制剂工艺技术的建模与仿真——颗粒技术视角
Pharmaceutics. 2020 Dec 24;13(1):22. doi: 10.3390/pharmaceutics13010022.
5
Progress in the development of stabilization strategies for nanocrystal preparations.纳米晶体制剂稳定策略的发展进展。
Drug Deliv. 2021 Dec;28(1):19-36. doi: 10.1080/10717544.2020.1856224.
6
Effect of the third component on the aging and crystallization of cinnarizine-soluplus® binary solid dispersion.第三组分对肉桂嗪-soluplus®二元固体分散体老化和结晶的影响。
Int J Pharm. 2020 Apr 30;580:119240. doi: 10.1016/j.ijpharm.2020.119240. Epub 2020 Mar 17.
7
Insights on role of polymers in precipitation of celecoxib from supersaturated solutions as assessed by focused beam reflectance measurement (FBRM).通过聚焦光束反射测量(FBRM)评估聚合物在塞来昔布过饱和溶液中沉淀的作用的见解。
Eur J Pharm Sci. 2019 Sep 1;137:104983. doi: 10.1016/j.ejps.2019.104983. Epub 2019 Jul 2.
8
Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion.成核和晶体生长抑制剂对超饱和拉西地平固体分散体体内外性能的协同作用。
Int J Pharm. 2019 Jul 20;566:594-603. doi: 10.1016/j.ijpharm.2019.06.010. Epub 2019 Jun 6.
9
Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.通过与磷脂的分子复合提高厄洛替尼的口服生物利用度和治疗效果。
Int J Pharm. 2017 Dec 20;534(1-2):1-13. doi: 10.1016/j.ijpharm.2017.09.071. Epub 2017 Sep 29.
10
New multi-component solid forms of anti-cancer drug Erlotinib: role of auxiliary interactions in determining a preferred conformation.抗癌药物厄洛替尼的新型多组分固体形式:辅助相互作用在确定优选构象中的作用。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Jun 1;72(Pt 3):291-300. doi: 10.1107/S2052520616003607. Epub 2016 May 13.